BioAge Labs, Inc. (BIOA)

BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	215.57	354.35	24.96	27.64
Short-Term Investments	70.21	-	-	-
Cash & Short-Term Investments	285.78	354.35	24.96	27.64
Cash Growth	-14.56%	1319.84%	-9.72%	-
Accounts Receivable	0.52	-	-	-
Other Current Assets	4.54	2.75	0.35	0.39
Total Current Assets	290.83	357.1	25.31	28.03
Net Property, Plant & Equipment	3.86	0.79	0.52	0.37
Long-Term Investments	10.18	0.1	0.1	-
Other Long-Term Assets	0.23	0.24	-	0.03
Total Assets	305.09	358.23	25.92	28.43
Accounts Payable	5.02	2	1.87	2.26
Accrued Expenses	7.26	11.75	7.94	3.38
Short-Term Debt	-	-	20.67	-
Current Portion of Long-Term Debt	4.13	6	6	0.17
Current Portion of Leases	0.58	0.2	0.19	0.05
Unearned Revenue	7.51	7.83	3.31	-
Other Current Liabilities	-	-	18.18	-
Total Current Liabilities	24.49	27.78	58.17	5.86
Long-Term Debt	-	2.5	8.2	2.25
Long-Term Leases	2.43	-	-	-
Other Long-Term Liabilities	0.71	4.83	0.23	0.15
Total Long-Term Liabilities	3.13	7.33	8.43	2.41
Total Liabilities	27.63	35.11	66.6	8.27
Additional Paid-in Capital	584.66	575.69	8.14	5.12
Accumulated Other Comprehensive Income	0.28	0.25	0.16	0.17
Retained Earnings	-307.47	-252.81	-181.7	-117.85
Total Common Shareholders' Equity	277.46	323.13	-173.4	-112.56
Minority Interest	-	-	132.72	132.72
Shareholders' Equity	277.46	323.13	-40.67	20.16
Total Liabilities & Equity	305.09	358.23	25.92	28.43
Total Debt	7.13	8.7	35.07	2.47
Net Cash (Debt)	278.65	345.65	-10.11	25.18
Net Cash Growth	-19.38%	-	-	-
Net Cash Per Share	7.76	32.22	-6.04	15.06
Book Value	277.46	323.13	-173.4	-112.56
Book Value Per Share	7.73	30.12	-103.66	-67.33
Tangible Book Value	277.46	323.13	-173.4	-112.56
Tangible Book Value Per Share	7.73	30.12	-103.66	-67.33

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q